Treatment of headache using anti-CGRP antibodies
US12215145B2 · kind B2 · utility
0Cited by
40References
28Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 19, 2024 |
| Grant date | Feb 4, 2025 |
| Priority date | — |
| Expiry date | Mar 19, 2044 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/76
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods for immediate relief of migraine or headache are provided comprising the administration of an anti-CGRP antagonist antibody to a patient in need thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.